Lemaitre Vascular (LMAT) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Lemaitre Vascular (LMAT) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -429.00 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 803.00 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 260.00 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 574.00 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 764.00 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 835.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1,045.00 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 598.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 423.00 |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 1,094.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,094.00 |
| Mar 31, 2026 | 1,253.00 |
| Dec 31, 2025 | 1,245.00 |
| Sep 30, 2025 | 2,122.00 |
| Jun 30, 2025 | 1,496.00 |
| Mar 31, 2025 | 357.00 |
| Dec 31, 2024 | 515.00 |
| Sep 30, 2024 | 456.00 |
| Jun 30, 2024 | 206.00 |
| Mar 31, 2024 | 305.00 |
| Dec 31, 2023 | -64.00 |
| Sep 30, 2023 | -503.00 |
| Jun 30, 2023 | 141.00 |
| Mar 31, 2023 | 302.00 |
| Dec 31, 2022 | 184.00 |
| Sep 30, 2022 | -449.00 |
| Jun 30, 2022 | -747.00 |
| Mar 31, 2022 | 437.00 |
| Dec 31, 2021 | -553.00 |
| Sep 30, 2021 | 241.00 |